The objective of Sophion’s Ion Channel Modulation Symposium (ICMS) is to provide a valuable platform to bring together international, leading researchers from academia as well as scientists from the pharmaceutical industry in order to promote and stimulate discussion, develop collaborations, and share their latest advances and discuss current, cutting edge research focused on the modulation of this important class of receptors as therapeutic targets.
Invited speakers will address four main research areas: ion channels in pain, ion channels and cancer, the cardiac safety of ion channel modulating compounds and advances in stem cells as tools for ion channel research. The meeting aims to cover a broad range of ion channels, from voltage-gated to ligand-gated channels, present important issues in the modulation of these targets for drug discovery purposes, and look at new technologies and approaches to this research.
ICMS gathers a broad range of people, from academia, CROs and pharmaceutical companies, and provides more than 20 speakers with an audience of 130 and has been fully attended since we introduced the symposium in 2016. The meeting was initiated due to the absence of a high-level ion channel drug discovery conference in Europe.
See what some of our guests think about ICMS: